CNB.MU Stock Analysis
CN
Uncovered
Fortress Biotech Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Fortress Biotech, Inc. (Fortress) is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. Fortress has nine marketed prescription pharmaceutical products and over 30 programs in development at Fortress, and at its partner companies. Its product candidates are used in oncology, rare diseases, and gene therapy. Its commercialized products include Qbrexza, a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane capsule is an oral retinoid indicated for the treatment of severe recalcitrant nodular acne; Ximino extended-release capsule is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; and Targadox is a tetracycline-class drug indicated as adjunctive therapy for severe acne. It operates in two operating and reportable segments: Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.